Wakefulness-Promoting Agents

Known as: Wakefulness Promoting Agents, Wake Promoting Substances, Wake-Promoting Drugs 
A specific category of drugs that prevent sleepiness by specifically targeting sleep-mechanisms in the brain. They are used to treat DISORDERS OF… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1985-2018
0246819852018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
There is limited information available concerning the treatment of daytime somnolence associated with Parkinson's disease (PD… (More)
Is this relevant?
Review
2015
Review
2015
STUDY OBJECTIVES To perform a meta-analysis of the effect of wakefulness-promoting agents (modafinil and armodafinil) in patients… (More)
Is this relevant?
2013
2013
Hypoxic brain damage might explain persistent sleepiness in some continuous positive airway pressure-compliant obstructive sleep… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2009
2009
STUDY OBJECTIVE Rebound hypersomnolence (RHS: increased sleep following increased wake) is a limiting side-effect of many wake… (More)
Is this relevant?
2009
2009
Conscious coronary sinus-cannulated dogs were used to assess the hemodynamic effects and local cardiac norepinephrine (NE) and… (More)
  • table 1
  • figure 1
  • table 2
  • figure 3
  • figure 2
Is this relevant?
2008
2008
Recent studies suggest a significant association between obesity and attention-deficit/hyperactivity disorder (ADHD). The factors… (More)
Is this relevant?
2007
2007
Current research on sleep using experimental animals is limited by the expense and time-consuming nature of traditional EEG/EMG… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2004
2004
STUDY OBJECTIVE To evaluate the economic burden of patients suffering from narcolepsy. DESIGN Cross-sectional study… (More)
Is this relevant?
2003
2003
Patients with Parkinson's disease (PD) and parkinsonian syndromes (eg, dementia with Lewy bodies, multisystem atrophy, and Shy… (More)
Is this relevant?
2000
2000
Here, we suggest that the relative effectiveness of informational and emotional appeals in persuasive communications may depend… (More)
Is this relevant?